Star Equity (STRR) Competitors $11.23 -0.03 (-0.26%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock STRR vs. INO, APYX, PDEX, OBIO, NSPR, FONR, NTRB, EDAP, PSTV, and VANIShould you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include Inovio Pharmaceuticals (INO), Apyx Medical (APYX), Pro-Dex (PDEX), Orchestra BioMed (OBIO), InspireMD (NSPR), Fonar (FONR), Nutriband (NTRB), Edap Tms (EDAP), Plus Therapeutics (PSTV), and Vivani Medical (VANI). These companies are all part of the "medical equipment" industry. Star Equity vs. Its Competitors Inovio Pharmaceuticals Apyx Medical Pro-Dex Orchestra BioMed InspireMD Fonar Nutriband Edap Tms Plus Therapeutics Vivani Medical Inovio Pharmaceuticals (NASDAQ:INO) and Star Equity (NASDAQ:STRR) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation. Do institutionals and insiders hold more shares of INO or STRR? 26.8% of Inovio Pharmaceuticals shares are held by institutional investors. Comparatively, 3.8% of Star Equity shares are held by institutional investors. 2.3% of Inovio Pharmaceuticals shares are held by company insiders. Comparatively, 33.5% of Star Equity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is INO or STRR more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to Star Equity's net margin of -2.81%. Star Equity's return on equity of -3.81% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Inovio PharmaceuticalsN/A -163.32% -96.41% Star Equity -2.81%-3.81%-2.84% Do analysts recommend INO or STRR? Inovio Pharmaceuticals currently has a consensus target price of $8.80, suggesting a potential upside of 240.43%. Star Equity has a consensus target price of $5.00, suggesting a potential downside of 55.77%. Given Inovio Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Inovio Pharmaceuticals is more favorable than Star Equity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inovio Pharmaceuticals 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.29Star Equity 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Which has more volatility and risk, INO or STRR? Inovio Pharmaceuticals has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500. Does the media prefer INO or STRR? In the previous week, Inovio Pharmaceuticals and Inovio Pharmaceuticals both had 4 articles in the media. Star Equity's average media sentiment score of 0.76 beat Inovio Pharmaceuticals' score of 0.73 indicating that Star Equity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inovio Pharmaceuticals 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Star Equity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, INO or STRR? Star Equity has higher revenue and earnings than Inovio Pharmaceuticals. Star Equity is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInovio Pharmaceuticals$220K624.40-$107.25M-$2.61-0.99Star Equity$140.06M0.22-$4.77M-$1.30-8.70 SummaryInovio Pharmaceuticals beats Star Equity on 8 of the 15 factors compared between the two stocks. Get Star Equity News Delivered to You Automatically Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STRR vs. The Competition Export to ExcelMetricStar EquityDIVERSIFIED OPS IndustryMulti-Sector SectorNASDAQ ExchangeMarket Cap$31.20M$16.02B$14.71B$10.32BDividend YieldN/A3.49%3.34%4.69%P/E Ratio-8.7011.929.9326.63Price / Sales0.229.007.44179.51Price / CashN/A42.0339.5962.20Price / Book0.762.362.086.58Net Income-$4.77M$953.12M$923.61M$275.87M7 Day Performance-4.28%-3.00%-2.32%-0.76%1 Month Performance14.31%-0.47%-0.07%5.90%1 Year Performance189.13%10.68%9.13%32.58% Star Equity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STRRStar Equity1.0795 of 5 stars$11.31+0.4%$5.00-55.8%+168.7%$31.20M$140.06M-8.701,300Analyst ForecastINOInovio Pharmaceuticals3.7748 of 5 stars$2.39-0.8%$8.80+268.2%-51.7%$127.01M$220K-0.92320Analyst ForecastAPYXApyx Medical1.6449 of 5 stars$2.84-1.7%N/A+151.3%$107.41M$46.51M-6.31270News CoverageAnalyst ForecastPDEXPro-Dex3.0499 of 5 stars$32.82-3.0%$56.00+70.6%+18.5%$107.06M$66.59M12.16140News CoverageAnalyst ForecastOBIOOrchestra BioMed3.1383 of 5 stars$2.73-1.4%$13.50+394.5%-42.6%$105.50M$2.94M-1.494News CoverageAnalyst ForecastNSPRInspireMD2.943 of 5 stars$2.42-3.2%$4.50+86.0%-8.7%$100.97M$7.07M-3.2350FONRFonar1.5515 of 5 stars$15.89-0.7%N/A-1.9%$98.52M$104.35M12.92480NTRBNutriband2.2391 of 5 stars$7.84flat$13.00+65.8%+15.0%$94.35M$2.58M-2.7310News CoverageAnalyst ForecastGap DownEDAPEdap Tms3.1853 of 5 stars$2.20-3.9%$8.50+286.4%-17.2%$82.26M$69.18M-3.61230Positive NewsAnalyst ForecastPSTVPlus Therapeutics3.7793 of 5 stars$0.82-7.7%$8.00+874.3%-46.9%$81.51MN/A-0.3720Analyst ForecastGap DownVANIVivani Medical2.9668 of 5 stars$1.37-2.8%$4.00+192.0%+25.9%$81.16MN/A-3.0420 Related Companies and Tools Related Companies Inovio Pharmaceuticals Competitors Apyx Medical Competitors Pro-Dex Competitors Orchestra BioMed Competitors InspireMD Competitors Fonar Competitors Nutriband Competitors Edap Tms Competitors Plus Therapeutics Competitors Vivani Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STRR) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredBig Oil Firm Stakes $1 Billion in Startup That Could Kill Big OilOn September 22, the unthinkable happened... One of the world's biggest oil producers poured $1 billion int...Stansberry Research | SponsoredBetter than Bitcoin?Bitcoin’s historic run may be ending — and Weiss Ratings’ Juan Villaverde, who’s nailed every major crypto bul...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Star Equity Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Star Equity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
